These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1232941

  • 1. Toxic epidermal necrolysis associated with allopurinol administration.
    Ellman MH, Fretzin DF, Olson W.
    Arch Dermatol; 1975 Aug; 111(8):986-90. PubMed ID: 1232941
    [Abstract] [Full Text] [Related]

  • 2. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC, EuroSCAR Study Group.
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [Abstract] [Full Text] [Related]

  • 3. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, Chucherd P, Konyoung P, Vannaprasaht S, Choonhakarn C, Pisuttimarn P, Sangviroon A, Tassaneeyakul W.
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [Abstract] [Full Text] [Related]

  • 4. Death caused by toxic epidermal necrolysis (Lyell syndrome).
    Ventura F, Fracasso T, Leoncini A, Gentile R, de Stefano F.
    J Forensic Sci; 2010 May; 55(3):839-41. PubMed ID: 20345799
    [Abstract] [Full Text] [Related]

  • 5. [Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome].
    Hammer B, Link A, Wagner A, Böhm M.
    Dtsch Med Wochenschr; 2001 Nov 23; 126(47):1331-4. PubMed ID: 11719858
    [Abstract] [Full Text] [Related]

  • 6. [Fatal liver necrosis due to allopurinol].
    Pereira S, Almeida J, Silva AO, Quintas M, Candeias O, Freitas F.
    Acta Med Port; 1998 Dec 23; 11(12):1141-4. PubMed ID: 10192993
    [Abstract] [Full Text] [Related]

  • 7. [Fatal outcome in allopurinol hypersensitivity syndrome].
    Kluger E.
    Ugeskr Laeger; 1998 Feb 16; 160(8):1179-80. PubMed ID: 9492630
    [Abstract] [Full Text] [Related]

  • 8. [Toxic epidermal necrolysis (Lyell syndrome)].
    Dürst UN, Müller E, Pfister T, Künzi W, Zellweger G, Spiegel MV.
    Schweiz Med Wochenschr; 1986 May 24; 116(21):713-20. PubMed ID: 3726503
    [Abstract] [Full Text] [Related]

  • 9. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?
    Dainichi T, Uchi H, Moroi Y, Furue M.
    Dermatology; 2007 May 24; 215(1):86-8. PubMed ID: 17587850
    [No Abstract] [Full Text] [Related]

  • 10. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
    Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M, RegiSCAR study group.
    Pharmacogenet Genomics; 2008 Feb 24; 18(2):99-107. PubMed ID: 18192896
    [Abstract] [Full Text] [Related]

  • 11. Allopurinol in dermatology.
    Tsai TF, Yeh TY.
    Am J Clin Dermatol; 2010 Feb 24; 11(4):225-32. PubMed ID: 20509717
    [Abstract] [Full Text] [Related]

  • 12. Basic measures and systemic medical treatment of patients with toxic epidermal necrolysis.
    Hanken I, Schimmer M, Sander CA.
    J Dtsch Dermatol Ges; 2010 May 24; 8(5):341-6. PubMed ID: 19845819
    [Abstract] [Full Text] [Related]

  • 13. Toxic epidermal necrolysis associated with quinidine administration.
    Adornato MC.
    N Y State Dent J; 2000 Mar 24; 66(3):38-40. PubMed ID: 10808726
    [Abstract] [Full Text] [Related]

  • 14. Allopurinol hypersensitivity syndrome: a preventable severe cutaneous adverse reaction?
    Lee HY, Ariyasinghe JT, Thirumoorthy T.
    Singapore Med J; 2008 May 24; 49(5):384-7. PubMed ID: 18465047
    [Abstract] [Full Text] [Related]

  • 15. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM.
    Cornea; 2007 Feb 24; 26(2):123-9. PubMed ID: 17251797
    [Abstract] [Full Text] [Related]

  • 16. Allopurinol pharmacogenetics: assessment of potential clinical usefulness.
    Zineh I, Mummaneni P, Lyndly J, Amur S, La Grenade LA, Chang SH, Rogers H, Pacanowski MA.
    Pharmacogenomics; 2011 Dec 24; 12(12):1741-9. PubMed ID: 22118056
    [Abstract] [Full Text] [Related]

  • 17. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Lee HY, Pang SM, Thamotharampillai T.
    J Am Acad Dermatol; 2008 Aug 24; 59(2):352-3. PubMed ID: 18638633
    [No Abstract] [Full Text] [Related]

  • 18. [Toxic epidermal necrolysis (Lyell's syndrome) caused by allopurinol].
    Knezević A, Frković A, Francetić I, Dobrić I.
    Lijec Vjesn; 1987 Jul 24; 109(7):272-4. PubMed ID: 3669890
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Delayed reepithelialization and scarring deregulation following drug-induced toxic epidermal necrolysis.
    Paquet P, Jacob E, Quatresooz P, Jacquemin D, Piérard GE.
    Burns; 2007 Feb 24; 33(1):100-4. PubMed ID: 17079086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.